Business Context and Reporting Period
Company: Chicago Atlantic BDC, Inc. (Ticker: LIEN)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and Six Months Ended June 30, 2025
Business Overview: An externally managed, closed-end business development company (BDC) and regulated investment company (RIC) focused on investing in the cannabis ecosystem and other complex, regulated industries. The company primarily invests in first-lien senior secured loans, senior secured notes, and equity-related securities.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2025 | Three Months Ended June 30, 2025 | As of June 30, 2025 |
|---|---|---|---|
| Total Investment Income | $25,003,040 | $13,080,038 | - |
| Net Investment Income | $15,313,028 | $7,664,607 | - |
| Net Increase in Net Assets from Operations | $16,198,622 | $8,584,265 | - |
| Net Asset Value (NAV) per Share | - | - | $13.23 |
| Total Net Assets | - | - | $301,843,563 |
| Cash and Cash Equivalents | - | - | $13,829,354 |
| Revolving Line of Credit Outstanding | - | - | $5,000,000 |
| Portfolio Fair Value | - | - | $307,499,004 |
| Distributions Declared (Per Share) | $0.68 (Total for 6 months) | $0.34 | - |
Material Changes vs. Prior Period
- Revenue Growth: Total investment income for the six months ended June 30, 2025, increased to $25.0 million from $5.8 million in the same period in 2024. This significant increase is primarily attributable to the Loan Portfolio Acquisition completed in October 2024, which expanded the portfolio's amortized cost by approximately $253.3 million year-over-year.
- Expense Structure: Net operating expenses increased to $9.7 million for the six months ended June 30, 2025, compared to $4.4 million in the prior year period. This reflects higher management and incentive fees due to the larger asset base, partially offset by expense waivers totaling $1.1 million under the Expense Limitation Agreement.
- Portfolio Composition: The portfolio remains heavily concentrated in the cannabis industry, representing 78.5% of total investments at fair value. The portfolio consists of 33 portfolio companies as of June 30, 2025, up from 28 at year-end 2024.
- Debt Utilization: The company entered into a new $100 million senior secured revolving credit facility in February 2025. As of June 30, 2025, $5 million was drawn, with $95 million available.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management continues to focus on maximizing risk-adjusted returns through current income from debt investments and capital appreciation. The company maintains an active pipeline of approximately $780.3 million in potential investments.
- Subsequent Events:
- Dividend: On August 12, 2025, the Board approved a quarterly cash dividend of $0.34 per share, payable October 10, 2025.
- Repayment: On July 31, 2025, the company received a full principal repayment of approximately $38.7 million from STIIIZY Inc. (Shryne Group Inc.).
- Risks:
- Cannabis Industry Risk: Significant exposure to the cannabis sector subjects the company to federal illegality risks, regulatory changes, and potential enforcement actions that could impact portfolio company operations and collateral value.
- Concentration Risk: As of June 30, 2025, the top three portfolio companies represented 39.5% of the portfolio's fair value.
- Interest Rate Risk: Approximately 76.2% of debt investments are floating-rate (PRIME or SOFR). Rising rates increase borrowing costs but generally increase investment income, though floors may limit downside protection.
- Unusual Items: The company incurred no transaction expenses related to the Loan Portfolio Acquisition in the current period, as the acquisition closed in the prior fiscal year. However, $1.1 million in operating expenses were waived by the Adviser under the Expense Limitation Agreement.
Investor Verification Checklist
- Portfolio Concentration: Verify the credit quality and performance of the top three portfolio companies, which comprise nearly 40% of the portfolio.
- Cannabis Regulatory Environment: Monitor changes in U.S. federal cannabis policy and enforcement that could impact the viability of the primary investment sector.
- Expense Waivers: Confirm the duration and terms of the Expense Limitation Agreement (currently capped through September 30, 2025) and the Adviser's commitment to future waivers.
- Liquidity Position: Assess the company's ability to fund unfunded commitments ($16.2 million) and maintain distributions given the recent draw on the revolving credit facility.
- Market Discount: Note that as of August 13, 2025, the stock traded at a discount of approximately 21.3% to its NAV of $13.23.